ERBB2 and breast carcinoma: Gene expression profiling studies of clinical samples from breast tumors have identified the intrinsic luminal, HER2-enriched, basal, claudin-low and normal breast cancer subtypes [11,12,13], and validity of these subtypes has been shown also in breast cancer cell lines [7,14,15,16,17].